jillian michaels glp-1 Jillian Michaels Weighs in on
Description
Phase 3 TRIUMPH-4 trial results The Phase 3 TRIUMPH-4 trial enrolled 445 adults with obesity or overweight and knee osteoarthritis, testing 9 mg and 12 mg maintenance doses over 68 weeks
Because we have zero markup on medications, you pay exactly what the pharmacy charges us either way
Orals: Metsera candidates + YP05002 Two distinct oral GLP-1 families now in development some overlap risk, but Pfizer can segment by tolerability, dosing, and combination potential
Treat it like a meal, not a drink
Not a significant source of protein
Less iron
